EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome



Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome



Cochrane Database of Systematic Reviews 2014(9): Cd002918-Cd002918



This review is an update of a review first published in Issue 2, 2003, which was substantially updated in Issue 7, 2010. The concept that many neuropathic pain syndromes (traditionally this definition would include complex regional pain syndromes (CRPS)) are "sympathetically maintained pains" has historically led to treatments that interrupt the sympathetic nervous system. Chemical sympathectomies use alcohol or phenol injections to destroy ganglia of the sympathetic chain, while surgical ablation is performed by open removal or electrocoagulation of the sympathetic chain or by minimally invasive procedures using thermal or laser interruption. To review the evidence from randomised, double blind, controlled trials on the efficacy and safety of chemical and surgical sympathectomy for neuropathic pain, including complex regional pain syndrome. Sympathectomy may be compared with placebo (sham) or other active treatment, provided both participants and outcome assessors are blind to treatment group allocation. On 2 July 2013, we searched CENTRAL, MEDLINE, EMBASE, and the Oxford Pain Relief Database. We reviewed the bibliographies of all randomised trials identified and of review articles and also searched two clinical trial databases, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform, to identify additional published or unpublished data. We screened references in the retrieved articles and literature reviews and contacted experts in the field of neuropathic pain. Randomised, double blind, placebo or active controlled studies assessing the effects of sympathectomy for neuropathic pain and CRPS. Two review authors independently assessed trial quality and validity, and extracted data. No pooled analysis of data was possible. Only one study satisfied our inclusion criteria, comparing percutaneous radiofrequency thermal lumbar sympathectomy with lumbar sympathetic neurolysis using phenol in 20 participants with CRPS. There was no comparison of sympathectomy versus sham or placebo. No dichotomous pain outcomes were reported. Average baseline scores of 8-9/10 on several pain scales fell to about 4/10 initially (1 day) and remained at 3-5/10 over four months. There were no significant differences between groups, except for "unpleasant sensation", which was higher with radiofrequency ablation. One participant in the phenol group experienced post sympathectomy neuralgia, while two in the radiofrequency group and one in the phenol group complained of paraesthesia during needle positioning. All participants had soreness at the injection site. The practice of surgical and chemical sympathectomy for neuropathic pain and CRPS is based on very little high quality evidence. Sympathectomy should be used cautiously in clinical practice, in carefully selected patients, and probably only after failure of other treatment options. In these circumstances, establishing a clinical register of sympathectomy may help to inform treatment options on an individual patient basis.

(PDF emailed within 0-6 h: $19.90)

Accession: 051999750

Download citation: RISBibTeXText

PMID: 23999944

DOI: 10.1002/14651858.CD002918.pub3



Related references

Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheral neuropathic pain and central pain states following spinal cord injury. Pain Research & Management 9(2): 89-97, 2004

Endoscopic thoracic sympathectomy for posttraumatic complex regional pain syndrome. European Journal of Trauma and Emergency Surgery 37(6): 597-604, 2011

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions. Journal of Pain Research 9(): 763-770, 2016

Fear of pain in children and adolescents with neuropathic pain and complex regional pain syndrome. Pain 157 Suppl 1: S90-S97, 2016

From wheelchair dependency to the ability to walk: lumbar sympathectomy as a treatment for complex regional pain syndrome. Schmerz 23(4): 399-402, 2010

Tunneled epidural catheter infections in noncancer pain: increased risk in patients with neuropathic pain/complex regional pain syndrome. Clinical Journal of Pain 22(1): 82-89, 2005

Management of lower limb complex regional pain syndrome type 1: an evaluation of percutaneous radiofrequency thermal lumbar sympathectomy versus phenol lumbar sympathetic neurolysis--a pilot study. Anesthesia and Analgesia 106(2): 647-9, Table of Contents, 2008

Predictors of Long-Term Outcome of Thoracic Sympathectomy in Patients with Complex Regional Pain Syndrome Type 2. World Neurosurgery 92: 74-82, 2017

Neuropathic pain and prolonged regional inflammation as two distinct symptomatological components in complex regional pain syndrome with patchy osteoporosis: A pilot study. Pain 72(1-2): 277-282, 1997

The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesthesia and Analgesia 92(2): 488-495, 2001

Lumbar and thoracic sympathetic radiofrequency lesioning in complex regional pain syndrome. Pain Practice 2(3): 250-256, 2006

Reflex sympathetic dystrophy syndrome (RSDS), complex regional pain syndrome-type 1 (CRPS 1), neuropathic pain: an equine perspective. Journal of equine veterinary science 16(11): 463-468, 1996

Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Thescientificworldjournal 8: 229-236, 2008